
Dr. Ben Bikman discusses how insulin may impair the body's ability to produce GLP-1, revealing a deeper metabolic issue.
📢 Ask Dr. Bikman’s Digital Mind (multilingual): https://benbikman.com/ben-bikmans-digital-ai-mind 📢 Dr. Bikman’s Community & Coaching Site: https://insuliniq.com Summary: GLP-1 has become one of the most talked-about hormones in modern medicine, largely due to the rise of GLP-1 receptor agonist drugs for weight loss. In this lecture, Dr. Ben Bikman shifts the focus from how GLP-1 affects insulin to the overlooked reverse question: how insulin affects GLP-1. That shift reveals a deeper metabolic story about how chronic hyperinsulinemia may impair the body’s ability to produce GLP-1 over time. Dr. Bikman first clarifies a key misconception. While GLP-1 can stimulate insulin under artificial conditions, in a real meal its dominant role is to slow gastric emptying, suppress glucagon, and reduce the need for insulin. In that sense, GLP-1 functions primarily as an insulin-sparing hormone. This makes the reverse question critical: what happens when the body produces less GLP-1? Evidence shows that insulin-resistant, obese, prediabetic, and type 2 diabetic individuals consistently have a blunted GLP-1 response. Mechanistic studies indicate that chronic exposure to high insulin can…
Host: Dr. Ben Bikman
Organizations: Insulin IQ
Products: GLP-1 receptor agonist drugs
Places: type 2 diabetic, obese, prediabetic
Explore listener stats, chart rankings, contacts and more on the The Metabolic Classroom with Dr. Ben Bikman podcast page.